Group Post |
COVID-19 hits a US plateau: Why aren’t cases going up or down? |
FNUOvviyaa |
Group Post |
‘A very hard road ahead’ for China as COVID-19 cases spiral |
FNUOvviyaa |
Group Post |
New global action pledge to end TB by 2030 |
FNUOvviyaa |
Group Post |
Africa's top public health body gets $100 mln from World Bank |
FNUOvviyaa |
Group Post |
Germany’s governing coalition argues over COVID restrictions |
FNUOvviyaa |
Group Post |
The BA.5 Wave Is What COVID Normal Looks Like |
FNUOvviyaa |
Group Post |
Doctors say search for monkeypox cases needs to look beyond men who have sex with men |
FNUOvviyaa |
Group Post |
US doctor issues warning of many undiagnosed polio cases |
FNUOvviyaa |
Group Post |
Outrage as Paris hospitals chief raises idea of charging unvaccinated patients |
FNUOvviyaa |
Group Post |
Moderna says dual variant booster with Beta more effective vs Omicron than current shot |
FNUOvviyaa |
Group Post |
Feds buy 500,000 more vaccine doses to fight monkeypox |
FNUOvviyaa |
Group Post |
Gottlieb: Drug shortage ‘isn’t like what we had with baby formula’ |
FNUOvviyaa |
Group Post |
EU drops nearly all of its order for Valneva COVID vaccine |
FNUOvviyaa |
Group Post |
How the U.S. Let 20 Million Doses of Monkeypox Vaccine Expire |
FNUOvviyaa |
Group Post |
Vaccine makers prep bird flu shot for humans 'just in case'; rich nations lock in supplies |
FNUOvviyaa |
Group Post |
COVID-19 vaccine hesitancy and uptake among participants from different racial and ethnic groups |
FNUOvviyaa |
Group Post |
Silent spread of monkeypox may be a wakeup call for the world |
FNUOvviyaa |
Group Post |
WHO panel backs use of Omicron-adapted vaccine as booster dose |
FNUOvviyaa |
Group Post |
French medics protest hospital crisis, deepened by COVID |
FNUOvviyaa |
Group Post |
Flu and RSV on the decline but Covid hospitalizations rise |
FNUOvviyaa |
Group Post |
What is parechovirus? Signs, symptoms and risk factors of the virus infecting babies across the country |
FNUOvviyaa |
Group Post |
Senate Democrats propose $21 billion in new COVID-19 funding amid stalemate |
FNUOvviyaa |
Group Post |
The 'traumatic experience' of US monkeypox patients |
FNUOvviyaa |
Group Post |
COVID endangers fragile health systems in Pacific nations |
FNUOvviyaa |
Group Post |
FDA advisers vote in support of Paxlovid approval for Covid-19 treatment in high-risk adults |
FNUOvviyaa |
Recent Comments